Loading provider…
Loading provider…
Child & Adolescent Psychiatry Physician in Orange, CA
NPI: 1003133521Primary Practice Location
UNIVERSITY OF CALIFORNIA IRVINE MEDICAL CENTER
101 The City Dr S, Orange, CA
Primary Employer
UCI Department of Psychiatry
ucihealth.org
HQ Phone
Get MD, MBA David's Phone Numberphone_androidMobile
Get MD, MBA David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2012 - 2026

American Board of Preventive Medicine
Clinical Informatics

American Board of Psychiatry and Neurology
Psychiatry

American Board of Psychiatry and Neurology
Child & Adolescent Psychiatry
UC Irvine School of Medicine
medschool.uci.edu
Medical School
Until 2010
University of California (Irvine)
Fellowship • Child and Adolescent Psychiatry
2013 - 2015
Residency • Psychiatry
2010 - 2013
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 23 | 29 |
Treatment of 22q11.2 deletion syndrome-associated schizophrenia with comorbid anxiety and panic disorder.
Authors: Candace Borders, Amanda Suzuki, David Safani
Publication Date: 2017-05-13
Authors: Francine Kaufman, Daina Dreimane
Journal: Diabetes Res Clin Pract
Publication Date: 2006-07-11
Authors: Rana Movahedi, Christopher Cooke, Jeffrey Wang, Syed Hussain, Jahan Tajran, Gligor Gucev, Arif Musa
Journal: J Clin Anesth
Publication Date: 2020-05-27
Lead Sponsor: Boehringer Ingelheim
Intervention / Treatment: DRUG: Brigimadlin
Lead Sponsor: Riphah International University
Intervention / Treatment: OTHER: Pilates Exercise - Online, OTHER: Pilates Exercise - Supervised
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Enzalutamide, DRUG: Abiraterone, DRUG: JSB462